Deutsche Bank Aktiengesellschaft Has Lowered Expectations for Synthomer (LON:SYNT) Stock Price

Synthomer (LON:SYNTGet Free Report) had its price target cut by equities researchers at Deutsche Bank Aktiengesellschaft from GBX 96 to GBX 62 in a research note issued to investors on Monday, MarketBeat.com reports. The firm presently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s price objective suggests a potential upside of 16.44% from the stock’s current price.

Separately, JPMorgan Chase & Co. decreased their target price on Synthomer from GBX 200 to GBX 120 and set a “neutral” rating for the company in a research report on Friday, October 10th. Four analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Synthomer has a consensus rating of “Hold” and a consensus target price of GBX 90.50.

View Our Latest Report on SYNT

Synthomer Stock Performance

LON SYNT traded down GBX 1.34 during trading hours on Monday, hitting GBX 53.25. The company had a trading volume of 1,584,090 shares, compared to its average volume of 615,181. The business has a 50 day moving average of GBX 59.74 and a 200-day moving average of GBX 63.35. The company has a market cap of £87.04 million, a PE ratio of -1.04, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79. Synthomer has a 1-year low of GBX 45.40 and a 1-year high of GBX 157.60. The company has a debt-to-equity ratio of 78.27, a quick ratio of 0.97 and a current ratio of 1.90.

Insider Activity

In related news, insider Michael Willome purchased 63,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 11th. The shares were purchased at an average price of GBX 49 per share, for a total transaction of £30,870. 5.03% of the stock is currently owned by corporate insiders.

About Synthomer

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide.

Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.

Read More

Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.